Javascript must be enabled to continue!
Acute Pulmonary Embolism In Non-Hospitalized Covid-19 Patients Referred To CTPA By Emergency Department
View through CrossRef
Abstract
Objectives: To evaluate the prevalence of acute pulmonary embolism (APE) in non-hospitalized COVID-19 patients referred to CT pulmonary angiography (CTPA) by Emergency Department.Methods: From March 14 to April 6, 2020, 72 non-hospitalized patients referred by Emergency Department to CTPA for COVID-19 pneumonia were retrospectively identified. Relevant clinical and laboratory data and CT scan findings were collected for each patient. CTPA scans were reviewed by two radiologists to determinate the presence or absence of APE. Clinical classification, lung involvement of COVID-19 pneumonia and CT total severity score were compared between APE group and Non-APE group.Results: APE was identified in 13 (18%) CTPA scans. The mean age and D-dimer of patients from APE group were higher in comparison with Non-APE group (74.4 vs. 59.6 years, p=0.008 and 7.29 vs. 3.29 µg/ml, p=0.011). There was no significant difference between APE and Non-APE groups concerning clinical type, COVID-19 pneumonia lung lesions (ground-glass opacity: 85 vs. 97%; consolidation: 69 vs. 68%; crazy paving: 38% vs. 37%; linear reticulation: 69 vs. 78%), CT severity score (6.3 vs. 7.1, p=0.365), quality of CTPA (1.8 vs. 2.0, p=0.518) and pleural effusion (38% vs. 19%, p=0.146).Conclusions: Non-hospitalized patients with COVID-19 pneumonia referred to CT-scan by Emergency Departments are at risk of APE. Presence of APE was not limited to severe or critical clinical type of COVID-19 pneumonia.
Springer Science and Business Media LLC
Title: Acute Pulmonary Embolism In Non-Hospitalized Covid-19 Patients Referred To CTPA By Emergency Department
Description:
Abstract
Objectives: To evaluate the prevalence of acute pulmonary embolism (APE) in non-hospitalized COVID-19 patients referred to CT pulmonary angiography (CTPA) by Emergency Department.
Methods: From March 14 to April 6, 2020, 72 non-hospitalized patients referred by Emergency Department to CTPA for COVID-19 pneumonia were retrospectively identified.
Relevant clinical and laboratory data and CT scan findings were collected for each patient.
CTPA scans were reviewed by two radiologists to determinate the presence or absence of APE.
Clinical classification, lung involvement of COVID-19 pneumonia and CT total severity score were compared between APE group and Non-APE group.
Results: APE was identified in 13 (18%) CTPA scans.
The mean age and D-dimer of patients from APE group were higher in comparison with Non-APE group (74.
4 vs.
59.
6 years, p=0.
008 and 7.
29 vs.
3.
29 µg/ml, p=0.
011).
There was no significant difference between APE and Non-APE groups concerning clinical type, COVID-19 pneumonia lung lesions (ground-glass opacity: 85 vs.
97%; consolidation: 69 vs.
68%; crazy paving: 38% vs.
37%; linear reticulation: 69 vs.
78%), CT severity score (6.
3 vs.
7.
1, p=0.
365), quality of CTPA (1.
8 vs.
2.
0, p=0.
518) and pleural effusion (38% vs.
19%, p=0.
146).
Conclusions: Non-hospitalized patients with COVID-19 pneumonia referred to CT-scan by Emergency Departments are at risk of APE.
Presence of APE was not limited to severe or critical clinical type of COVID-19 pneumonia.
Related Results
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Best approach in d-dimer algorithm to exclude pulmonary thromboembolism: a comparative study
Best approach in d-dimer algorithm to exclude pulmonary thromboembolism: a comparative study
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
Segmentation of Acute Pulmonary Embolism in Computed Tomography Pulmonary Angiography Using the Deep Learning Method
Segmentation of Acute Pulmonary Embolism in Computed Tomography Pulmonary Angiography Using the Deep Learning Method
Abstract
Background
Pulmonary embolism is a type of thromboembolism seen in the main pulmonary artery and its branches. This study aimed to diagnose acute pulmonary emboli...
Segmentation of Acute Pulmonary Embolism in Computed Tomography Pulmonary Angiography Using the Deep Learning Method
Segmentation of Acute Pulmonary Embolism in Computed Tomography Pulmonary Angiography Using the Deep Learning Method
Abstract
Background
Pulmonary embolism is a type of thromboembolism seen in the main pulmonary artery and its branches. This study aimed to diagnose acute pulmonary emboli...
Finding an alternative diagnosis does not justify increased use of CT-pulmonary angiography
Finding an alternative diagnosis does not justify increased use of CT-pulmonary angiography
Abstract
Background
The increased use of computed tomography pulmonary angiography (CTPA) is often justified by finding alternative diagnoses exp...
End-tidal carbon dioxide in the diagnosis of acute pulmonary embolism in hospitalized adult patients
End-tidal carbon dioxide in the diagnosis of acute pulmonary embolism in hospitalized adult patients
Pulmonary embolism (PE) causes 100,000 deaths and contributes to over 4 billion dollars of annual healthcare costs. Acute PE is a diagnostic challenge as symptoms vary widely and a...
Pulmonary embolism in patients in acute COVID-19, long-COVID and post-COVID syndrome
Pulmonary embolism in patients in acute COVID-19, long-COVID and post-COVID syndrome
<p><strong>Abstract.</strong> COVID-19 is a disease caused by the SARS-CoV-2 virus, which, after entering a living organism, uses the ACE-2 protein as a receptor ...

